Yajing Zhu

Company: Novo Nordisk

Job title: Head of Real World Science: Obesity & Liver

Seminars:

Panel Discussion: Considering the Future of Obesity Therapeutics: Beyond Appetite Suppression for More Varied Treatment Options 3:30 pm

Discussing the limitations of current therapies that primarily focus on appetite suppression Exploring new targets and delving into emerging areas of research, such as targeting metabolic pathways, gut microbiota modulation, and precision medicine approaches Exploring the potential of combining different therapies and modalities to achieve more comprehensive and sustainable weight lossRead more

day: Day Two

Evaluating the Obesity Treatments In Use Using Real World Data on Patient Experience to Better Future Drugs for More Effective Weight Loss 9:30 am

Investigating current obesity treatments through real-world patient experience data to identify areas for improvement Analysing patient feedback and outcomes to understand the effectiveness and limitations of existing weight loss drugs Informing the development of future obesity medications by leveraging real-world data insights for more targeted and successful weight managementRead more

day: Day One